DRP Biomedical

DRP Biomedical is a Japanese biotechnology company specializing in regenerative medicine, particularly in the field of bone grafting and dental reconstruction. The company utilizes its proprietary carbonate apatite technology to develop biomaterials that mimic natural bone structure and promote effective bone regeneration. Its flagship products, such as Cytrans, are used in dental surgeries to treat bone defects and support implant stability. Unlike traditional synthetic materials, DRP's carbonate apatite is designed to be resorbed by osteoclasts and replaced by the patient's own natural bone. DRP Biomedical focuses on bridging the gap between basic research in biomaterials and clinical applications to improve patient outcomes in oral and maxillofacial surgery. The company maintains a strong partnership with GC Corporation for the global distribution of its regenerative products.